Cronos CRON
NASDAQ CRON
$3.22 -0.07 (-2.13%)
At close: Aug 20, 2026 · 4:00 PM EDT

Cronos (CRON) Notes Payables (2019 - 2025)

Cronos (CRON) posted quarterly Notes Payables of $3000.0 for Q2 2025, down 85.71% year-over-year from $21000.0 in Q2 2024, and down 76.92% quarter-over-quarter from $13000.0 in Q1 2025.

Cronos (CRON) Notes Payables (2019 - 2025) Analysis & Trends

Cronos' Notes Payables history runs 7 years deep, the most recent figure standing at $3000.0 for Q2 2025.

  • In Q2 2025, Notes Payables fell 85.71% year-over-year to $3000.0; the TTM figure through Jun 2025 stood at $3000.0 (down 85.71% YoY), while the FY2024 annual figure was $40000.0, down 60.78% from the prior year.
  • Notes Payables for Q2 2025 stood at $3000.0, down from $13000.0 in the prior quarter.
  • The five-year high for Notes Payables was $272.3 million in Q1 2021, with the low at $3000.0 in Q2 2025.
  • The 5-year median for Notes Payables is $91000.0 (2023), against an average of $27.6 million.
  • The sharpest annual moves came in 2022 and 2023: Notes Payables plunged 99.9% in 2022, then surged 580.0% in 2023.
  • Cronos' Notes Payables stood at $14.4 million in 2021, then slumped by 99.9% to $15000.0 in 2022, then soared by 580.0% to $102000.0 in 2023, then slumped by 60.78% to $40000.0 in 2024, then plunged by 92.5% to $3000.0 in 2025.
  • Business Quant data shows CRON's Notes Payables at $3000.0 in Q2 2025, $13000.0 in Q1 2025, and $40000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Cronos 1.20 Bn 407.87 Mn 28.45 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 3,000.00
Mar 31, 2025 13,000.00
Dec 31, 2024 40,000.00
Sep 30, 2024 192,000.00
Jun 30, 2024 21,000.00
Mar 31, 2024 118,000.00
Dec 31, 2023 102,000.00
Sep 30, 2023 29,000.00
Jun 30, 2023 37,000.00
Mar 31, 2023 80,000.00
Dec 31, 2022 15,000.00
Sep 30, 2022 73,000.00
Jun 30, 2022 574,000.00
Mar 31, 2022 4.10 Mn
Dec 31, 2021 14.38 Mn
Sep 30, 2021 34.53 Mn
Jun 30, 2021 169.56 Mn
Mar 31, 2021 272.30 Mn
Dec 31, 2020 163.41 Mn
Sep 30, 2020 102.66 Mn